Damora Therapeutics (DMRA) Total Liabilities (2019 - 2026)
Damora Therapeutics (DMRA) reported Total Liabilities of $27.58 million for Q2 2026, up 907.2% from $2.74 million a year earlier and up 15.7% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Total Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Damora Therapeutics posted Total Liabilities of $20.15 million.
- Total Liabilities has a five-year compound annual growth rate of 27.0% (FY2020 to FY2025).
- By year, Total Liabilities came in at $1.3 million in FY2024 (-77.9%), $5.9 million in FY2023 (-48.4%), $11.44 million in FY2022 (+129.1%) and $4.99 million in FY2021 (-18.3%).
- The Q2 2026 figure ranks as the highest quarterly Total Liabilities since Q3 2020.
- Year over year, Total Liabilities gained in two of the last six quarters, with growth averaging 112.1%.
- The high point for year-over-year Total Liabilities in five years was Q2 2026 (growth of 907.2%); the low point was Q3 2021 (a decline of 96.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $23.84 million (Q1 2026), $20.15 million (Q4 2025) and $2.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Damora Therapeutics | 1.28 Bn | -57.65 Mn | - | 27.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.58 Mn |
| Mar 31, 2026 | 23.84 Mn |
| Dec 31, 2025 | 20.15 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 12.67 Mn |
| Jun 30, 2023 | 15.10 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 9.30 Mn |
| Jun 30, 2022 | 7.79 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 6.25 Mn |
API Access
Damora Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();